B'LANCE Trademark

Trademark Overview


On Wednesday, January 27, 2021, a trademark application was filed for B'LANCE with the United States Patent and Trademark Office. The USPTO has given the B'LANCE trademark a serial number of 90491917. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by VIVANT BIOTECHNOLOGY GmbH. The B'LANCE trademark is filed in the Pharmaceutical Products category with the following description:

Amino acids for medical purposes; Amino acids for veterinary purposes; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Dietetic substances adapted for medical use; Medicinal drinks; Medicinal infusions for rehydration, nutrition, and the delivery of pharmaceutical preparations to prevent and for the treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency syndrome, neurotransmitter imbalance and long covid; Medicines for human purposes for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss...
b'lance

General Information


Serial Number90491917
Word MarkB'LANCE
Filing DateWednesday, January 27, 2021
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7064715
Registration DateTuesday, May 30, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized letters "B'LANCE" with an incomplete circle behind the letters "LANC".
Goods and ServicesAmino acids for medical purposes; Amino acids for veterinary purposes; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Dietetic substances adapted for medical use; Medicinal drinks; Medicinal infusions for rehydration, nutrition, and the delivery of pharmaceutical preparations to prevent and for the treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency syndrome, neurotransmitter imbalance and long covid; Medicines for human purposes for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and/or drug intoxications and hangover, muscle fatigue after excessive physical stress, Serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Pharmaceutical preparations for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency syndrome, neurotransmitter imbalance and long covid; Pharmaceuticals for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, Serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Pre-filled Syringes sold filled with hyaluronic acid, pharmaceuticals and supplements, all containing vitamins, amino acids, proteins, creatine, electrolytes, trace elements, coenzymes, vital nutrients, and carbohydrates; Medicated serums for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Sodium salts for medical purposes; Vitamin preparations; Medicinal infusions, namely, intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceuticals and natural remedy preparations for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, Serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Medicines for human purposes, namely, intravenous bags sold filled with intravenous fluids used for rehydration, nutrition, and the delivery of pharmaceutical preparations for humans; Medicinal infusions, namely, intravenous fluids used for rehydration, nutrition, and the delivery of pharmaceutical preparations for humans
Pseudo MarkBALANCE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIVANT BIOTECHNOLOGY GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBerlin 10719
DE

Party NameVIVANT BIOTECHNOLOGY GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBerlin 10719
DE

Party NameVIVANT BIOTECHNOLOGY GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerlin 10719
DE

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 8, 2023EXAMINERS AMENDMENT MAILED
Wednesday, February 8, 2023CASE RETURNED TO EXAMINATION
Wednesday, February 8, 2023NOTICE OF ALLOWANCE CANCELLED
Wednesday, February 1, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 1, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, January 30, 2023ASSIGNED TO PETITION STAFF
Tuesday, January 10, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 29, 2022TTAB RELEASE CASE TO TRADEMARKS
Thursday, September 29, 2022OPPOSITION TERMINATED NO. 999999
Thursday, September 29, 2022OPPOSITION DISMISSED NO. 999999
Tuesday, June 28, 2022OPPOSITION INSTITUTED NO. 999999
Tuesday, June 28, 2022OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 25, 2022ASSIGNED TO LIE
Friday, April 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 28, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 15, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 15, 2021FINAL REFUSAL E-MAILED
Wednesday, December 15, 2021FINAL REFUSAL WRITTEN
Tuesday, November 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 1, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 1, 2021NON-FINAL ACTION WRITTEN
Saturday, August 14, 2021ASSIGNED TO EXAMINER
Thursday, April 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, April 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 30, 2021NEW APPLICATION ENTERED